<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36074464</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Sociodemographic Characteristics and Comorbidities of Patients With Long COVID and Persistent Olfactory Dysfunction.</ArticleTitle><Pagination><StartPage>e2230637</StartPage><MedlinePgn>e2230637</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2230637</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2022.30637</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Determining the characteristics, type, and severity of olfactory dysfunction in patients with long COVID is important for the prognosis and potential treatment of the affected population.</AbstractText><AbstractText Label="OBJECTIVE">To describe the sociodemographic and clinical features of patients with long COVID who develop persistent olfactory dysfunction.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This cross-sectional study, conducted at a rehabilitation center at a public university in the Amazon region of Brazil between September 9, 2020, and October 20, 2021, comprised 219 patients with long COVID and self-reported neurologic symptoms. Of these 219 patients, 139 received a diagnosis of chronic olfactory dysfunction, as confirmed by the Connecticut Chemosensory Clinical Research Center (CCCRC) test.</AbstractText><AbstractText Label="EXPOSURE">Clinical diagnosis of long COVID.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Electronic case report forms were prepared for the collection of sociodemographic and clinical data. Patients' sense of smell was evaluated via a CCCRC test, and the association of olfactory dysfunction with aspects of daily life was recorded using a questionnaire.</AbstractText><AbstractText Label="RESULTS">Of the 219 patients included in the study, 164 (74.9%) were women, 194 (88.6%) were between 18 and 59 years of age (mean [SD] age, 43.2 [12.9] years), 206 (94.1%) had more than 9 years of education, and 115 (52.5%) had a monthly income of up to US $192.00. In the study group, 139 patients (63.5%) had some degree of olfactory dysfunction, whereas 80 patients (36.5%) had normosmia. Patients with olfactory dysfunction had a significantly longer duration of long COVID symptoms than those in the normosmia group (mean [SD], 242.7 [101.9] vs 221.0 [97.5] days; P&#x2009;=&#x2009;.01). Among patients with anosmia, there was a significant association between olfactory dysfunction and daily activities, especially in terms of impairment in hazard detection (21 of 31 patients [67.7%]), personal hygiene (21 of 31 patients [67.7%]), and food intake (21 of 31 patients [67.7%]). Univariable logistic regression analyses found that ageusia symptoms were associated with the occurrence of olfactory dysfunction (odds ratio [OR], 11.14 [95% CI, 4.76-26.07]; P&#x2009;&lt;&#x2009;.001), whereas headache (OR, 0.41 [95% CI, 0.22-0.76]; P&#x2009;&lt;&#x2009;.001) and sleep disorders (OR, 0.48 [95% CI, 0.26-0.92]; P&#x2009;=&#x2009;.02) showed an inverse association with the occurrence of olfactory dysfunction.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Olfactory dysfunction is one of the most important long-term neurologic symptoms of COVID-19, with the highest prevalence seen among women, adults, and outpatients. Patients with olfactory dysfunction may experience persistent severe hyposmia or anosmia more than 1 year from the onset of symptoms, suggesting the possibility of the condition becoming a permanent sequela.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mendes Paranhos</LastName><ForeName>Alna Carolina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Tropical Medicine Center, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biological and Health Center, Par&#xe1; State University, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazareth Dias</LastName><ForeName>&#xc1;pio Ricardo</ForeName><Initials>&#xc1;R</Initials><AffiliationInfo><Affiliation>Biological and Health Center, Par&#xe1; State University, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado da Silva</LastName><ForeName>Livia Caroline</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Biological and Health Center, Par&#xe1; State University, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieira Hennemann Koury</LastName><ForeName>Gisele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Biological and Health Center, Par&#xe1; State University, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Jesus Sousa</LastName><ForeName>Emanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Biological and Health Center, Par&#xe1; State University, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerasi</LastName><ForeName>Ant&#xf4;nio Jos&#xe9;</ForeName><Initials>AJ</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Biological Science Center, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cosmopolita College, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Givago Silva</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Tropical Medicine Center, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biological Science Center, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim&#xf5;es Quaresma</LastName><ForeName>Juarez Ant&#xf4;nio</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Tropical Medicine Center, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biological and Health Center, Par&#xe1; State University, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magno Falc&#xe3;o</LastName><ForeName>Luiz F&#xe1;bio</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Biological and Health Center, Par&#xe1; State University, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012903" MajorTopicYN="N">Smell</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>11</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36074464</ArticleId><ArticleId IdType="pmc">PMC9459661</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.30637</ArticleId><ArticleId IdType="pii">2795995</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV. Long COVID-19: challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr. 2021;15(1):145-146. doi:10.1016/j.dsx.2020.12.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, et al. . Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022;74(7):1191-1198. doi:10.1093/cid/ciab611</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. . Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568. doi:10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi:10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4(5):e2111417. doi:10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou SH, Beghi E, Helbok R, et al. ; GCS-NeuroCOVID Consortium and ENERGY Consortium . Global incidence of neurological manifestations among patients hospitalized with COVID-19&#x2014;a report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw Open. 2021;4(5):e2112131. doi:10.1001/jamanetworkopen.2021.12131</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12131</ArticleId><ArticleId IdType="pmc">PMC8114143</ArticleId><ArticleId IdType="pubmed">33974053</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud M, Thibault C, Le Normand F, et al. . Clinical outcomes for patients with anosmia 1 year after COVID-19 diagnosis. JAMA Netw Open. 2021;4(6):e2115352. doi:10.1001/jamanetworkopen.2021.15352</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.15352</ArticleId><ArticleId IdType="pmc">PMC8226421</ArticleId><ArticleId IdType="pubmed">34165581</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafar A, Lasso A, Shorr R, Hutton B, Kilty S. Olfactory recovery following infection with COVID-19: a systematic review. PLoS One. 2021;16(11):e0259321. doi:10.1371/journal.pone.0259321</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259321</ArticleId><ArticleId IdType="pmc">PMC8577770</ArticleId><ArticleId IdType="pubmed">34752471</ArticleId></ArticleIdList></Reference><Reference><Citation>Croy I, Nordin S, Hummel T. Olfactory disorders and quality of life&#x2014;an updated review. Chem Senses. 2014;39(3):185-194. doi:10.1093/chemse/bjt072</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjt072</ArticleId><ArticleId IdType="pubmed">24429163</ArticleId></ArticleIdList></Reference><Reference><Citation>Boesveldt S, Postma EM, Boak D, et al. . Anosmia&#x2014;a clinical review. Chem Senses. 2017;42(7):513-523. doi:10.1093/chemse/bjx025</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjx025</ArticleId><ArticleId IdType="pmc">PMC5863566</ArticleId><ArticleId IdType="pubmed">28531300</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkholi SMA, Abdelwahab MK, Abdelhafeez M. Impact of the smell loss on the quality of life and adopted coping strategies in COVID-19 patients. Eur Arch Otorhinolaryngol. 2021;278(9):3307-3314. doi:10.1007/s00405-020-06575-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06575-7</ArticleId><ArticleId IdType="pmc">PMC7814376</ArticleId><ArticleId IdType="pubmed">33464401</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller A, Malaspina D. Hidden consequences of olfactory dysfunction: a patient report series. BMC Ear Nose Throat Disord. 2013;13(1):8. doi:10.1186/1472-6815-13-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6815-13-8</ArticleId><ArticleId IdType="pmc">PMC3733708</ArticleId><ArticleId IdType="pubmed">23875929</ArticleId></ArticleIdList></Reference><Reference><Citation>Pence TS, Reiter ER, DiNardo LJ, Costanzo RM. Risk factors for hazardous events in olfactory-impaired patients. JAMA Otolaryngol Head Neck Surg. 2014;140(10):951-955. doi:10.1001/jamaoto.2014.1675</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2014.1675</ArticleId><ArticleId IdType="pubmed">25170573</ArticleId></ArticleIdList></Reference><Reference><Citation>Saussez S, Lechien JR, Hopkins C. Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered. Eur Arch Otorhinolaryngol. 2021;278(7):2187-2191. doi:10.1007/s00405-020-06285-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06285-0</ArticleId><ArticleId IdType="pmc">PMC7480210</ArticleId><ArticleId IdType="pubmed">32909060</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscutti A, Delvecchio G, Pigoni A, et al. . Olfactory and gustatory dysfunctions in SARS-CoV-2 infection: a systematic review. Brain Behav Immun Health. 2021;15:100268. doi:10.1016/j.bbih.2021.100268</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100268</ArticleId><ArticleId IdType="pmc">PMC8129998</ArticleId><ArticleId IdType="pubmed">34027497</ArticleId></ArticleIdList></Reference><Reference><Citation>World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.281053</ArticleId><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(suppl 1):S31-S34. doi:10.4103/sja.SJA_543_18</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/sja.SJA_543_18</ArticleId><ArticleId IdType="pmc">PMC6398292</ArticleId><ArticleId IdType="pubmed">30930717</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Brayne C, Feigin VL, et al. . Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology. Eur J Epidemiol. 2015;30(7):569-576. doi:10.1007/s10654-015-0034-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-015-0034-5</ArticleId><ArticleId IdType="pubmed">26088602</ArticleId></ArticleIdList></Reference><Reference><Citation>Cain WS, Gent JF, Goodspeed RB, Leonard G. Evaluation of olfactory dysfunction in the Connecticut Chemosensory Clinical Research Center. Laryngoscope. 1988;98(1):83-88. doi:10.1288/00005537-198801000-00017</Citation><ArticleIdList><ArticleId IdType="doi">10.1288/00005537-198801000-00017</ArticleId><ArticleId IdType="pubmed">3336267</ArticleId></ArticleIdList></Reference><Reference><Citation>Fen&#xf3;lio GHM, Anselmo-Lima WT, Tomazini GC, et al. Validation of Connecticut olfactory test (CCCRC) adapted to Brazil. Braz J Otorhinolaryngol. Published online November 6, 2020. doi:10.1016/j.bjorl.2020.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjorl.2020.09.013</ArticleId><ArticleId IdType="pmc">PMC9483934</ArticleId><ArticleId IdType="pubmed">33272838</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos REA, da Silva MG, do Monte Silva MCB, et al. . Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: a systematic review. Am J Otolaryngol. 2021;42(2):102889. doi:10.1016/j.amjoto.2020.102889</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102889</ArticleId><ArticleId IdType="pmc">PMC7833280</ArticleId><ArticleId IdType="pubmed">33445036</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinato G, Fabbris C, Polesel J, et al. . Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020;323(20):2089-2090. doi:10.1001/jama.2020.6771</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6771</ArticleId><ArticleId IdType="pmc">PMC7177631</ArticleId><ArticleId IdType="pubmed">32320008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, Place S, et al. ; COVID-19 Task Force of YO-IFOS . Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335-344. doi:10.1111/joim.13089</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13089</ArticleId><ArticleId IdType="pmc">PMC7267446</ArticleId><ArticleId IdType="pubmed">32352202</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan CH, Faraji F, Prajapati DP, Ostrander BT, DeConde AS. Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int Forum Allergy Rhinol. 2020;10(7):821-831. doi:10.1002/alr.22592</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22592</ArticleId><ArticleId IdType="pmc">PMC7264572</ArticleId><ArticleId IdType="pubmed">32329222</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Borsetto D, Fabbris C, et al. . Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19. JAMA Otolaryngol Head Neck Surg. 2020;146(8):729-732. doi:10.1001/jamaoto.2020.1379</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2020.1379</ArticleId><ArticleId IdType="pmc">PMC7333173</ArticleId><ArticleId IdType="pubmed">32614442</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Min P, Lee S, Kim SW. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020;35(18):e174. doi:10.3346/jkms.2020.35.e174</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e174</ArticleId><ArticleId IdType="pmc">PMC7211515</ArticleId><ArticleId IdType="pubmed">32383370</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann DH, Tsukahara T, Weinreb C, et al. . Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19&#x2013;associated anosmia. Sci Adv. 2020;6(31):eabc5801. doi:10.1126/sciadv.abc5801</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5801</ArticleId><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang F, Wang Y. COVID-19 anosmia: high prevalence, plural neuropathogenic mechanisms, and scarce neurotropism of SARS-CoV-2? Viruses. 2021;13(11):2225. doi:10.3390/v13112225</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112225</ArticleId><ArticleId IdType="pmc">PMC8625547</ArticleId><ArticleId IdType="pubmed">34835030</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty RL. The mechanisms of smell loss after SARS-CoV-2 infection. Lancet Neurol. 2021;20(9):693-695. doi:10.1016/S1474-4422(21)00202-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00202-7</ArticleId><ArticleId IdType="pmc">PMC8324112</ArticleId><ArticleId IdType="pubmed">34339627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Hopkins C, Sandison A, et al. . Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia. J Laryngol Otol. 2020;134(12):1123-1127. doi:10.1017/S0022215120002455</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215120002455</ArticleId><ArticleId IdType="pmc">PMC7729153</ArticleId><ArticleId IdType="pubmed">33190655</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Levallois S, et al. . COVID-19&#x2013;related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med. 2021;13(596):eabf8396. doi:10.1126/scitranslmed.abf8396</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C, Lechien JR, Saussez S. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival. Med Hypotheses. 2021;146:110406. doi:10.1016/j.mehy.2020.110406</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110406</ArticleId><ArticleId IdType="pmc">PMC7678428</ArticleId><ArticleId IdType="pubmed">33246692</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryche B, St Albin A, Murri S, et al. . Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav Immun. 2020;89:579-586. doi:10.1016/j.bbi.2020.06.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.032</ArticleId><ArticleId IdType="pmc">PMC7332942</ArticleId><ArticleId IdType="pubmed">32629042</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, et al. . Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168-175. doi:10.1038/s41593-020-00758-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurink B, Roos E, Radonic T, et al. . Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe. 2020;1(7):e290-e299. doi:10.1016/S2666-5247(20)30144-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30144-0</ArticleId><ArticleId IdType="pmc">PMC7518879</ArticleId><ArticleId IdType="pubmed">33015653</ArticleId></ArticleIdList></Reference><Reference><Citation>Prem B, Liu DT, Besser G, et al. . Long-lasting olfactory dysfunction in COVID-19 patients. Eur Arch Otorhinolaryngol. 2022;279(7):3485-3492. doi:10.1007/s00405-021-07153-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-07153-1</ArticleId><ArticleId IdType="pmc">PMC8578909</ArticleId><ArticleId IdType="pubmed">34757458</ArticleId></ArticleIdList></Reference><Reference><Citation>Moraschini V, Reis D, Sacco R, Calasans-Maia MD. Prevalence of anosmia and ageusia symptoms among long-term effects of COVID-19. Oral Dis. 2021. doi:10.1111/odi.13919</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.13919</ArticleId><ArticleId IdType="pmc">PMC8242542</ArticleId><ArticleId IdType="pubmed">34002923</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Hummel T, Hopkins C, et al. . High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post&#x2013;COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation. Rhinology. 2021;59(6):517-527. doi:10.4193/Rhin21.249</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin21.249</ArticleId><ArticleId IdType="pubmed">34553706</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Reed RR, Lane AP. Chronic inflammation directs an olfactory stem cell functional switch from neuroregeneration to immune defense. Cell Stem Cell. 2019;25(4):501-513. doi:10.1016/j.stem.2019.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2019.08.011</ArticleId><ArticleId IdType="pmc">PMC6778045</ArticleId><ArticleId IdType="pubmed">31523027</ArticleId></ArticleIdList></Reference><Reference><Citation>Auinger AB, Besser G, Liu DT, Renner B, Mueller CA. Long-term impact of olfactory dysfunction on daily life. Wien Klin Wochenschr. 2021;133(19-20):1004-1011. doi:10.1007/s00508-020-01751-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-020-01751-5</ArticleId><ArticleId IdType="pmc">PMC8500863</ArticleId><ArticleId IdType="pubmed">33084955</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DT, Prem B, Besser G, Renner B, Mueller CA. Olfactory-related quality of life adjustments in smell loss during the coronavirus-19 pandemic. Am J Rhinol Allergy. 2022;36(2):253-260. doi:10.1177/19458924211053118</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/19458924211053118</ArticleId><ArticleId IdType="pubmed">34704454</ArticleId></ArticleIdList></Reference><Reference><Citation>Speth MM, Singer-Cornelius T, Oberle M, Gengler I, Brockmeier SJ, Sedaghat AR. Mood, anxiety and olfactory dysfunction in COVID-19: evidence of central nervous system involvement? Laryngoscope. 2020;130(11):2520-2525. doi:10.1002/lary.28964</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.28964</ArticleId><ArticleId IdType="pmc">PMC7361512</ArticleId><ArticleId IdType="pubmed">32617983</ArticleId></ArticleIdList></Reference><Reference><Citation>Yom-Tov E, Lekkas D, Jacobson NC. Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation. J Affect Disord Rep. 2021;5:100156. doi:10.1016/j.jadr.2021.100156</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jadr.2021.100156</ArticleId><ArticleId IdType="pmc">PMC8154197</ArticleId><ArticleId IdType="pubmed">34075369</ArticleId></ArticleIdList></Reference><Reference><Citation>Graves AB, Bowen JD, Rajaram L, et al. . Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E &#x3b5;4 status. Neurology. 1999;53(7):1480-1487. doi:10.1212/WNL.53.7.1480</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.53.7.1480</ArticleId><ArticleId IdType="pubmed">10534255</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty RL. Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate? Lancet Neurol. 2017;16(6):478-488. doi:10.1016/S1474-4422(17)30123-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30123-0</ArticleId><ArticleId IdType="pubmed">28504111</ArticleId></ArticleIdList></Reference><Reference><Citation>Xydakis MS, Albers MW, Holbrook EH, et al. . Post-viral effects of COVID-19 in the olfactory system and their implications. Lancet Neurol. 2021;20(9):753-761. doi:10.1016/S1474-4422(21)00182-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00182-4</ArticleId><ArticleId IdType="pmc">PMC8324113</ArticleId><ArticleId IdType="pubmed">34339626</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Deiana G, Fois AG, et al. . Objective evaluation of anosmia and ageusia in COVID-19 patients: single-center experience on 72 cases. Head Neck. 2020;42(6):1252-1258. doi:10.1002/hed.26204</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.26204</ArticleId><ArticleId IdType="pmc">PMC7267244</ArticleId><ArticleId IdType="pubmed">32342566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Cabaraux P, Chiesa-Estomba CM, et al. . Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients. Head Neck. 2020;42(7):1583-1590. doi:10.1002/hed.26279</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.26279</ArticleId><ArticleId IdType="pmc">PMC7280665</ArticleId><ArticleId IdType="pubmed">32437033</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. &#x201c;Sniffin&#x2019; sticks&#x201d;: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses. 1997;22(1):39-52. doi:10.1093/chemse/22.1.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/22.1.39</ArticleId><ArticleId IdType="pubmed">9056084</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984;94(2, pt 1):176-178. doi:10.1288/00005537-198402000-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.1288/00005537-198402000-00004</ArticleId><ArticleId IdType="pubmed">6694486</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Wei Y, Yu D, Zhang J, Liu Y. Olfactory and gustatory function in healthy adult Chinese subjects. Otolaryngol Head Neck Surg. 2010;143(4):554-560. doi:10.1016/j.otohns.2010.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otohns.2010.05.010</ArticleId><ArticleId IdType="pubmed">20869568</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty RL, Marcus A, Lee WW. Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope. 1996;106(3, pt 1):353-356. doi:10.1097/00005537-199603000-00021</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005537-199603000-00021</ArticleId><ArticleId IdType="pubmed">8614203</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon C, Westervelt HJ, Jahn DR, Dressel JA, O&#x2019;Bryant SE. Normative performance on the Brief Smell Identification Test (BSIT) in a multi-ethnic bilingual cohort: a Project FRONTIER study. Clin Neuropsychol. 2013;27(6):946-961. doi:10.1080/13854046.2013.796406</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2013.796406</ArticleId><ArticleId IdType="pmc">PMC3742676</ArticleId><ArticleId IdType="pubmed">23634698</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen DT, Rumeau C, Gallet P, Jankowski R. Olfactory exploration: state of the art. Eur Ann Otorhinolaryngol Head Neck Dis. 2016;133(2):113-118. doi:10.1016/j.anorl.2015.08.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anorl.2015.08.038</ArticleId><ArticleId IdType="pubmed">26384780</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei G, Gu J, Gu Z, et al. . Olfactory dysfunction in patients with coronavirus disease 2019: a review. Front Neurol. 2022;12:783249. doi:10.3389/fneur.2021.783249</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.783249</ArticleId><ArticleId IdType="pmc">PMC8805677</ArticleId><ArticleId IdType="pubmed">35115994</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bartheld CS, Hagen MM, Butowt R. Prevalence of chemosensory dysfunction in COVID-19 patients: a systematic review and meta-analysis reveals significant ethnic differences. ACS Chem Neurosci. 2020;11(19):2944-2961. doi:10.1021/acschemneuro.0c00460</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00460</ArticleId><ArticleId IdType="pmc">PMC7571048</ArticleId><ArticleId IdType="pubmed">32870641</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimek L, Hagemann J, Hummel T, et al. . Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2). World Allergy Organ J. 2022;15(6):100653. doi:10.1016/j.waojou.2022.100653</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.waojou.2022.100653</ArticleId><ArticleId IdType="pmc">PMC9095455</ArticleId><ArticleId IdType="pubmed">35578676</ArticleId></ArticleIdList></Reference><Reference><Citation>Damm M, Pikart LK, Reimann H, et al. . Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. Laryngoscope. 2014;124(4):826-831. doi:10.1002/lary.24340</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.24340</ArticleId><ArticleId IdType="pubmed">23929687</ArticleId></ArticleIdList></Reference><Reference><Citation>Reden J, Mueller A, Mueller C, et al. . Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Arch Otolaryngol Head Neck Surg. 2006;132(3):265-269. doi:10.1001/archotol.132.3.265</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archotol.132.3.265</ArticleId><ArticleId IdType="pubmed">16549746</ArticleId></ArticleIdList></Reference><Reference><Citation>London B, Nabet B, Fisher AR, White B, Sammel MD, Doty RL. Predictors of prognosis in patients with olfactory disturbance. Ann Neurol. 2008;63(2):159-166. doi:10.1002/ana.21293</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21293</ArticleId><ArticleId IdType="pubmed">18058814</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucidi D, Molinari G, Silvestri M, et al. . Patient-reported olfactory recovery after SARS-CoV-2 infection: a 6-month follow-up study. Int Forum Allergy Rhinol. 2021;11(8):1249-1252. doi:10.1002/alr.22775</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22775</ArticleId><ArticleId IdType="pubmed">33539667</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussiere N, Mei J, Levesque-Boissonneault C, et al. . Persisting chemosensory impairments in 366 healthcare workers following COVID-19: an 11-month follow-up. Chem Senses. 2022;47:bjac010. doi:10.1093/chemse/bjac010</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjac010</ArticleId><ArticleId IdType="pubmed">35522081</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohla K, Veldhuizen MG, Green T, et al. . A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss. Rhinology. Published online April 10, 2022. doi:10.4193/Rhin21.415</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin21.415</ArticleId><ArticleId IdType="pmc">PMC11016179</ArticleId><ArticleId IdType="pubmed">35398877</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>